This pilot study assessed the prevalence of growth hormone deficiency (GHD) in individuals with chronic thoracic complete spinal cord injury (SCI) and evaluated the safety and efficacy of GH replacement therapy. Among 19 patients, 13 were identified with GHD. These patients were randomized to receive either GH therapy or placebo
